Status:
UNKNOWN
Postual Control in Pediatric Chiari I Malformation
Lead Sponsor:
Central Hospital, Nancy, France
Collaborating Sponsors:
University of Lorraine
Conditions:
Chiari I Malformation
Pediatric
Eligibility:
All Genders
6-18 years
Brief Summary
BACKGROUND: Chiari I malformation is a rare disease characterized by cerebellar amygdalae descent under the level of the foramen magnum. It causes troubles in cerebrospinal fluid circulation and direc...
Detailed Description
Chiari malformation is characterized by at least 5 mm descent of cerebellar tonsils below the foramen magnum, into the vertebral canal. Historical classification of this malformation consists in four ...
Eligibility Criteria
Inclusion
- Radiologically confirmed diagnosis of Chiari I malformation (first MRI realized up to 1/01/2018)
- ENT symptomes (dizziness, nystagmus, gait imbalance, migraines not due to the presence of Chiari Malformation)
Exclusion
- Lack of cooperation (cerebral palsy, severe behavioral troubles, orthopedic illness, severe visual impairment)
- Patient's consent for study non obtained.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04679792
Start Date
September 1 2019
End Date
September 1 2022
Last Update
December 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stella Irene
Vandœuvre-lès-Nancy, Lorraine, France, 54500